Vaginal microbiota from 4 subjects (2N, BZ, C9, N6) were collectively grown in vaginally-defined medium without glucose (o), or with 0.5% glucose (G), lactitol (tol), lactulose (lose), raffinose (R) o
Treatment options are limited for the approximately 40% of postmenopausal women worldwide who suffer from female sexual dysfunction (FSD). Neural stimulation has shown potential as a treatment for gen
The overall objective of the project was to examine associations between the composition of the vaginal microbiota and genitourinary menopausal symptoms, serum estrogen, and vaginal glycogen. Women (n
